CYTK - Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself
2024-05-17 11:58:33 ET
More on Cytokinetics
- Cytokinetics names Sung Lee as CFO
- Cytokinetics releases more data on hypertrophic cardiomyopathy drug aficamten
- Cytokinetics, Incorporated: Buyout Speculation Persists
- Cytokinetics: CEO Talks Down Buyout Prospects
- Cytokinetics drifts lower as CEO touts standalone strategy